您的购物车当前为空
ELOVL6-IN-5(compound B)是针对ELOVL6的抑制剂,后者为长链脂肪酸家族6的延长酶,负责饱和及单不饱和长链脂肪酸的延长,并且是糖尿病治疗中的有效靶点。此化合物能在饮食诱导肥胖(DIO)的小鼠模型中有效降低肝脏脂肪酸水平,尽管如此,通过ELOVL6-IN-5引起的ELOVL6抑制并未改善胰岛素抵抗问题。

ELOVL6-IN-5(compound B)是针对ELOVL6的抑制剂,后者为长链脂肪酸家族6的延长酶,负责饱和及单不饱和长链脂肪酸的延长,并且是糖尿病治疗中的有效靶点。此化合物能在饮食诱导肥胖(DIO)的小鼠模型中有效降低肝脏脂肪酸水平,尽管如此,通过ELOVL6-IN-5引起的ELOVL6抑制并未改善胰岛素抵抗问题。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
| 产品描述 | ELOVL6-IN-5 (compound B) acts as an inhibitor targeting the elongase enzyme of the long-chain fatty acid family 6 (ELOVL6). This enzyme is pivotal in the elongation process of saturated and monounsaturated long-chain fatty acids, marking it as a strategic target for diabetes intervention. In a mouse model of diet-induced obesity (DIO), ELOVL6-IN-5 effectively reduces hepatic fatty acid levels. However, it fails to enhance insulin sensitivity . |
| 分子量 | 439.45 |
| 分子式 | C20H20F3N3O3S |
| CAS No. | 1135000-36-0 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容